Senior professional, experienced in leading and developing patient-centric, noninvasive and programmable drug delivery technologies, transdermal drug permeation technologies, peptide and protein drug delivery as well as chronotherapeutics for pharmaceutical and medical device world leaders. Strengths include new technology product innovation, novel drug delivery technology assessment, IP management and preclinical product development.
As an active member in the American Association of Pharmaceutical Scientists (AAPS), I now serve as the Past Chair of the Dermatopharmaceutics Focus Group. I am also a member of the Controlled Release Society (CRS) serving as Industrial Editor for the CR...